Qinlock 50 mg, Tabletten - 90 Swissmedic Key 68199002 Registration Holder Deciphera Pharmaceuticals (Schweiz) AG Name Qinlock 50 mg, Tabletten Date of registration 07.10.2021 Introduction of Sequence 07.10.2021 ATC-Classification Ripretinib (L01EX19) Revision date WHO WHO-DDD Valid until 06.10.2026 Index Therapeuticus (BSV) 07.16.10. Show package size 90 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 19135.37 Limitation Yes Limitation text
Deductible 10 % Consumer price 19940.70 Feedback FB GTIN 7680681990024 Medication Code Synthetika Pharmacode Disponibility
Composition ripretinibum 50 mg, hypromellosi acetas succinas, cellulosum microcristallinum, lactosum monohydricum 179 mg, crospovidonum, silica colloidalis anhydrica, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Ripretinibum 50 mg
BAG: Active Agent Dose Ripretinibum 50 mg
Inactive agents Dose Cellulosum Microcristallinum Crospovidonum Hypromellosi Acetas Succinas Lactose Monohydrate 179 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
